SBIR/STTR Research Award
Not Available
Award amount
$999,913Program and phase
SBIR · Phase IIAward year
2010Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- BIOASSAY SYSTEMS, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- NWKBSNNFUFN3
- Solicitation number
- PHS2010-1
- Topic code
- NCI
Research abstract
The Contractor will develop pharmacodynamic assays for measuring a number of high-priority molecular targets. These assays will be suitable for pre-clinical and clinical testing to allow for rapid evaluation of treatment responses, gauge treatment correspondence to tumor stasis/regression, allow patient stratification for clinical trials and facilitate clinical validation of cancer therapeutics at early stages of drug development.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- TOPIC 229: PHASE I ERK DEV. OF MOLECULAR PHARMACODYNAMIC ASSAYS
- TOPIC 229: PHASE I AMPK DEV. OF MOLECULAR PHARMACODYNAMIC ASSAYS
- SBIR TOPIC 229 A ROBUST AND RIGOROUS PHARMACODYNAMIC ASSAY FOR PTP1B
- SBIR TOPIC 229 A ROBUST AND RIGOROUS PHARMACODYNAMIC ASSAY FOR AKT
- PRODUCING ERYTHROPOIETIN FROM HUMAN KIDNEY CELLS IN CULTURE.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Mini-reflectance confocal microscope (Mini-RCM) for aiding skin cancer diagnosis and treatment
- Development of small molecule therapeutics targeting AR-V7 for prostate cancer
- Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors
- Optimized targeted radiotherapy of pancreatic cancer
- Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis
Research funding history
7 SBIR/STTR records share this UEI (1983–2010). Reported award amounts total $1,705,408. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services